Acasti Pharma Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2018 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Acasti Pharma Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to 2023.
- Acasti Pharma Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.62M, a 34.9% increase year-over-year.
- Acasti Pharma Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$11.4M, a 72.7% increase year-over-year.
- Acasti Pharma Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$12.9M, a 69.7% increase from 2022.
- Acasti Pharma Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$42.4M, a 332% decline from 2021.
- Acasti Pharma Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$9.82M, a 50.1% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)